Greenleaf Health has joined forces with our Validant Group partners to reposition as one global regulatory brand: ELIQUENT Life Sciences.

ELIQUENT Life Sciences is the fusion of five global regulatory consultancies: Validant, Greenleaf Health, DataRevive, Oriel Stat-a-Matrix, and IDEC. The collective capabilities of the united ELIQUENT team enable a comprehensive approach that delivers integrated solutions to support pharmaceutical, biotechnology, medical device, and combination product companies navigating the complex regulatory landscape.

ELIQUENT’s unprecedented assembly of regulatory leaders, industry experts, and technical specialists bridge the spectrum of regulatory challenges across the product lifecycle. From thought to finish, concept to commerce, and strategy to execution— ELIQUENT Life Sciences is the singular regulatory resource that clients around the world trust.

LEARN MORE about our strategic repositioning.

Services at a Glance

With our comprehensive services and the wealth of knowledge available through our subject experts and network of technical specialists, clients can rely on unmatched guidance throughout the regulatory process.

Drug & Biological Products

Strategic advice on therapeutic product development, regulatory review, and postmarket requirements, as well as pipeline review and FDA milestone meeting preparation

Greenleaf Health

Greenleaf’s comprehensive services and wealth of experience ensure that clients can count on expert guidance as they navigate complex regulatory challenges.

Devices & Combination Products

Insight and guidance throughout the regulatory process for medical devices and combination products, including premarket strategic planning, submissions, and FDA meetings and engagement

Quality & Compliance

Full-service quality and compliance support, from on-site and remote compliance assessments, remediation, and inspection readiness to clinical quality systems and supply chain optimization

Cell & Gene Therapy

Specialized assistance with FDA interactions and submissions to support development, review, manufacturing, quality, and compliance for cell and gene therapies

Advisory Services

Regulatory risk assessments for life science investors — based on extensive research and due diligence, informed by Greenleaf’s deep regulatory knowledge

Regulatory Policy

Support for stakeholders in communicating effectively about FDA regulatory policy issues and in understanding, implementing, and complying with the FDA’s regulatory programs

Digital Health

Strategic guidance in navigating and complying with the complex landscape of FDA regulations and policies related to digital health technologies

Litigation Support

Expert opinions and FDA regulatory knowledge to support litigators and their clients in disputes related to medical devices, drug and biological products, and product quality, manufacturing, and compliance


Regulatory strategy, policy guidance, and compliance services for consumer products marketed in the cosmetics space

Why Greenleaf?

Greenleaf in Detail

To explore Greenleaf’s complete portfolio of capabilities and expert teams, view or download the PDFs below.